It had been reported that many tumor cell lines and primary clinical samples express permanently elevated levels of GRP78 [35], which might promote metastasis [36], inhibit caspase-4 [24] and pro-apoptotic pathways, support chemoresistance and thereby worsen the prognosis [35]. This evidence concerns the gene CASP4 and neoplasm.